A Quote by Peter Piot

I wouldn't be worried to sit next to someone with Ebola virus on the Tube as long as they don't vomit on you or something. This is an infection that requires very close contact.
We have to keep up our guard. We won't get the risk of Ebola to zero in the U.S. until we stop it in West Africa. And Ebola is hard to fight. It requires intensity. It requires speed and flexibility.
The more cases of Ebola infection we have, the more chances there are for the virus to mutate in a particular way that adapts it well to living in humans, replicating in humans, and perhaps transmitting from human to human.
Experiments suggest that if one particle of Ebola enters a person's bloodstream, it can cause a fatal infection. This may explain why many of the medical workers who came down with Ebola couldn't remember making any mistakes that might have exposed them.
We have learned a lot about how to treat Ebola, how to ensure that the people caring for people with Ebola do so minimizing their risk of infection.
We have seen that [Zika virus] has caused, and is causing, a whole series of problems for pregnant women and for their unborn children, and we are seeing that it is transmitted by mosquitos, and mosquitos are a serious matter during the summer in Florida. So we are very worried about those funds not being available. There is $500 million dollars available from the Ebola money that was not used. I think it is going to be used immediately.
What works most effectively for quelling disease outbreaks like Ebola is not quarantining huge populations. What works is focusing on and isolating the sick and those in direct contact with them as they are at highest risk of infection. This strategy worked with SARS, and it worked during the H1N1 flu pandemic.
The problem with Ebola is that it makes mistakes while it copies itself. The mistakes are actually good for Ebola because they help Ebola change, and as a result of this, as it jumps from one human body to the next, roughly half the time, it's got a mutation.
The launch of phase 1 Ebola vaccine studies is a first step in developing a vaccine that could be licensed and used in the field to protect not only the front line health care workers but also those living in areas where Ebola virus exists.
One of the things that's particularly nefarious about Ebola is that it continues to live in a dead person for some period of time after death. A person who's been dead for a day or two may still be seething with Ebola virus.
It is certainly possible that someone who has had contact with this patient could develop Ebola, but there is no doubt in my mind that we will stop it here.
Ebola has not yet come into contact with modern medicine in West Africa. But when protocols for the provision of high quality supportive care are followed, the case fatality rate for Ebola may be lower than 20 percent.
Just as the only reservoir for the typhus virus in nature is provided by man, so the only vector of infection is the louse. The bite of the louse is not virulent immediately after the infecting meal. It becomes so only towards the 7th day following infection.
Ebola isn't a respiratory virus. It doesn't spread through the airborne route. So it's not likely to spread like wildfire around the world and kill tens of thousands or hundreds of thousands of people. That's what I think of as the next big one.
Now she and I sit together in her room and eat chocolate, and I tell her that in a very long time when we both to go heaven, we should try to get chairs next to each other, close to the dessert table.
Ebola haunted Zaire because of corruption and political repression. The virus had no secret powers, nor was it unusually contagious. For centuries Ebola had lurked in the jungles of central Africa. Its emergence into human populations required the special assistance of humanity's greatest vices : greed, corruption, arrogance, tyranny, and callousness.
When a person survives Ebola, when they recover, they're not a carrier of the virus.
This site uses cookies to ensure you get the best experience. More info...
Got it!